Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound <i>vs</i> fluoroscopic guidance: A dual-institution retrospective comparative study. [PDF]
Hung ML+10 more
europepmc +1 more source
Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota. [PDF]
Xu X+7 more
europepmc +1 more source
Clinical efficacy of transjugular intrahepatic portosystemic shunt in treating esophageal variceal bleeding in patients with liver cirrhosis. [PDF]
Zhao Q, Zi Q, Dong G, Lu Y, Zhang Y.
europepmc +1 more source
Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt. [PDF]
Waidyaratne G+10 more
europepmc +1 more source
Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites. [PDF]
Luo SH+4 more
europepmc +1 more source
Numerous liver abscesses after transjugular intrahepatic portosystemic shunt for decompensated liver cirrhosis: A case report. [PDF]
Luo SH, Wang ZH, Chen J, Chen JY.
europepmc +1 more source
Related searches:
Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
Radiology, 2022Background Sarcopenia is frequently found in patients with cirrhosis and is associated with liver dysfunction, cirrhosis-related complications, and poorer quality of life.
Jiacheng Liu+10 more
semanticscholar +1 more source
Large spontaneous portosystemic shunt (SPSS) is associated with increased risk of HE in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS).
Yong Lv+15 more
semanticscholar +1 more source